BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akiba S, Koriyama C, Herrera-Goepfert R, Eizuru Y. Epstein-Barr virus associated gastric carcinoma: Epidemiological and clinicopathological features. Cancer Sci. 2008;99:195-201. [PMID: 18271915 DOI: 10.1111/j.1349-7006.2007.00674.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 89] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Cai L, Sun Y, Wang K, Guan W, Yue J, Li J, Wang R, Wang L. The Better Survival of MSI Subtype Is Associated With the Oxidative Stress Related Pathways in Gastric Cancer. Front Oncol 2020;10:1269. [PMID: 32850385 DOI: 10.3389/fonc.2020.01269] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Ribeiro J, Oliveira C, Malta M, Sousa H. Epstein-Barr virus gene expression and latency pattern in gastric carcinomas: a systematic review. Future Oncol 2017;13:567-79. [PMID: 28118740 DOI: 10.2217/fon-2016-0475] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
3 Kimura K, Ebihara Y, Tanaka K, Nakanishi Y, Asano T, Noji T, Kurashima Y, Murakami S, Nakamura T, Tsuchikawa T, Okamura K, Shichinohe T, Kanno-Okada H, Hirano S. Robot-assisted laparoscopic total gastrectomy for Epstein-Barr virus-associated multiple gastric cancer: A case report. Int J Surg Case Rep 2020;75:446-50. [PMID: 33002856 DOI: 10.1016/j.ijscr.2020.09.147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Yang G, Jian L, Lin X, Zhu A, Wen G. Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer. Dis Markers 2019;2019:1372571. [PMID: 31949544 DOI: 10.1155/2019/1372571] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
5 Bockorny B, Pectasides E. The emerging role of immunotherapy in gastric and esophageal adenocarcinoma. Future Oncol. 2016;12:1833-1846. [PMID: 27166503 DOI: 10.2217/fon-2016-0103] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
6 Camargo MC, Anderson WF, King JB, Correa P, Thomas CC, Rosenberg PS, Eheman CR, Rabkin CS. Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut 2011;60:1644-9. [PMID: 21613644 DOI: 10.1136/gut.2010.236737] [Cited by in Crossref: 89] [Cited by in F6Publishing: 86] [Article Influence: 8.1] [Reference Citation Analysis]
7 Tsai MH, Lin X, Shumilov A, Bernhardt K, Feederle R, Poirey R, Kopp-Schneider A, Pereira B, Almeida R, Delecluse HJ. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers. Oncotarget 2017;8:10238-54. [PMID: 28052012 DOI: 10.18632/oncotarget.14380] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 10.0] [Reference Citation Analysis]
8 Pikuła A, Kwietniewska M, Rawicz-Pruszyński K, Ciseł B, Skórzewska M, Gęca K, Franciszkiewicz-Pietrzak K, Kurylcio A, Mielko J, Polkowski WP. The importance of Epstein-Barr virus infection in the systemic treatment of patients with gastric cancer. Semin Oncol 2020;47:127-37. [PMID: 32402473 DOI: 10.1053/j.seminoncol.2020.04.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Luo B, Tang X, Jia Y, Wang Y, Chao Y, Zhao C. Sequence variation of Epstein-Barr virus (EBV) BZLF1 gene in EBV-associated gastric carcinomas and nasopharyngeal carcinomas in Northern China. Microbes and Infection 2011;13:776-82. [DOI: 10.1016/j.micinf.2011.04.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
10 Wang M, Busuttil RA, Pattison S, Neeson PJ, Boussioutas A. Immunological battlefield in gastric cancer and role of immunotherapies. World J Gastroenterol 2016; 22(28): 6373-6384 [PMID: 27605873 DOI: 10.3748/wjg.v22.i28.6373] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
11 Riquelme I, Saavedra K, Espinoza JA, Weber H, García P, Nervi B, Garrido M, Corvalán AH, Roa JC, Bizama C. Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. Oncotarget 2015;6:24750-79. [PMID: 26267324 DOI: 10.18632/oncotarget.4990] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 13.0] [Reference Citation Analysis]
12 Zhao D, Liu S, Sun L, Zhao Z, Liu S, Kuang X, Shu J, Luo B. Glypican-4 gene polymorphism (rs1048369) and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma. Virus Research 2016;220:52-6. [DOI: 10.1016/j.virusres.2016.04.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
13 He Y, Zhao X, Gao J, Fan L, Yang G, Cho WC, Chen H. Quantum dots-based immunofluorescent imaging of stromal fibroblasts Caveolin-1 and light chain 3B expression and identification of their clinical significance in human gastric cancer. Int J Mol Sci 2012;13:13764-80. [PMID: 23203033 DOI: 10.3390/ijms131113764] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
14 Yang K, Zhu H, Chen CC, Wen TF, Zhang WH, Liu K, Chen XZ, Guo DJ, Zhou ZG, Hu JK. Lessons Learned From a Case of Gastric Cancer After Liver Transplantation for Hepatocellular Carcinoma: A Case Report and Literatures Review. Medicine (Baltimore) 2016;95:e2666. [PMID: 26886605 DOI: 10.1097/MD.0000000000002666] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Li S, Zhang F, Li J, Hu X, Zhao W, Zhang K, Li J. The role of the Epstein-Barr virus-encoded BARF1 gene expressed in human gastric epithelial cells. Turk J Gastroenterol 2020;31:775-81. [PMID: 33361040 DOI: 10.5152/tjg.2020.18827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Chen JN, He D, Tang F, Shao CK. Epstein-Barr virus-associated gastric carcinoma: a newly defined entity. J Clin Gastroenterol. 2012;46:262-271. [PMID: 22392024 DOI: 10.1097/mcg.0b013e318249c4b8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 27] [Article Influence: 5.9] [Reference Citation Analysis]
17 Camargo MC, Kim WH, Chiaravalli AM, Kim KM, Corvalan AH, Matsuo K, Yu J, Sung JJ, Herrera-Goepfert R, Meneses-Gonzalez F, Kijima Y, Natsugoe S, Liao LM, Lissowska J, Kim S, Hu N, Gonzalez CA, Yatabe Y, Koriyama C, Hewitt SM, Akiba S, Gulley ML, Taylor PR, Rabkin CS. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut 2014;63:236-43. [PMID: 23580779 DOI: 10.1136/gutjnl-2013-304531] [Cited by in Crossref: 230] [Cited by in F6Publishing: 210] [Article Influence: 28.8] [Reference Citation Analysis]
18 Xing X, Jia S, Wu J, Feng Q, Dong B, Li B, Jia Y, Shan F, Li Y, Zhang Y, Hu Y, Wang X, Liu X, Yu W, Zhang L, Bu Z, Wu A, Li Z, Ji J. Clonality analysis of synchronous gastro-oesophageal junction carcinoma and distal gastric cancer by whole-exome sequencing. J Pathol 2017;243:165-75. [PMID: 28671728 DOI: 10.1002/path.4932] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
19 Ramos MFKP, Pereira MA, Dias AR, Faraj SF, Zilberstein B, Cecconello I, de Mello ES, Ribeiro Junior U. Lymphoepithelioma-like gastric carcinoma: clinicopathological characteristics and infection status. J Surg Res 2017;210:159-68. [PMID: 28457323 DOI: 10.1016/j.jss.2016.11.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
20 Ignatova E, Seriak D, Fedyanin M, Tryakin A, Pokataev I, Menshikova S, Vakhabova Y, Smirnova K, Tjulandin S, Ajani JA. Epstein-Barr virus-associated gastric cancer: disease that requires special approach. Gastric Cancer 2020;23:951-60. [PMID: 32514646 DOI: 10.1007/s10120-020-01095-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
21 Liu S, Wang X, Shu J, Zhao Z, Sun Z, Luo B. Sequence analysis of EBV immune evasion gene BNLF2a in EBV associated tumors and healthy individuals from nasopharyngeal carcinoma endemic and non-endemic regions of China. J Med Virol 2015;87:1946-52. [PMID: 25959517 DOI: 10.1002/jmv.24254] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
22 Watson S, Cyrta J, Lefevre M, Planchon JM, Louvet C, Servois V, Vaflard P, Bidard FC, Bieche I, Soularue E. Hyperprogressive Disease After Pembrolizumab Treatment in Advanced Epstein-Barr Virus-Associated Gastric Adenocarcinoma With ERBB2 Amplification. JCO Precis Oncol 2021;5:370-7. [PMID: 34994599 DOI: 10.1200/PO.20.00272] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Camargo MC, Murphy G, Koriyama C, Pfeiffer RM, Kim WH, Herrera-Goepfert R, Corvalan AH, Carrascal E, Abdirad A, Anwar M, Hao Z, Kattoor J, Yoshiwara-Wakabayashi E, Eizuru Y, Rabkin CS, Akiba S. Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis. Br J Cancer 2011;105:38-43. [PMID: 21654677 DOI: 10.1038/bjc.2011.215] [Cited by in Crossref: 96] [Cited by in F6Publishing: 91] [Article Influence: 8.7] [Reference Citation Analysis]
24 Fukayama M, Ushiku T. Epstein-Barr virus-associated gastric carcinoma. Pathol Res Pract. 2011;207:529-537. [PMID: 21944426 DOI: 10.1016/j.prp.2011.07.004] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 7.5] [Reference Citation Analysis]
25 Zhang Y, Chen JN, Dong M, Zhang ZG, Zhang YW, Wu JY, Du H, Li HG, Huang Y, Shao CK. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer. Hum Pathol 2017;63:128-38. [PMID: 28300576 DOI: 10.1016/j.humpath.2017.02.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
26 Cho J, Kang MS, Kim KM. Epstein-Barr Virus-Associated Gastric Carcinoma and Specific Features of the Accompanying Immune Response. J Gastric Cancer. 2016;16:1-7. [PMID: 27104020 DOI: 10.5230/jgc.2016.16.1.1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
27 Jia X, Guo T, Li Z, Zhang M, Feng Y, Dong B, Li Z, Hu Y, Li Z, Xing X, Jia S, Ji J. Clinicopathological and Immunomicroenvironment Characteristics of Epstein-Barr Virus-Associated Gastric Cancer in a Chinese Population. Front Oncol 2020;10:586752. [PMID: 33489884 DOI: 10.3389/fonc.2020.586752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Kim Y, Shin A, Gwack J, Ko KP, Kim CS, Park SK, Hong YC, Kang D, Yoo KY. Epstein-Barr virus antibody level and gastric cancer risk in Korea: a nested case-control study. Br J Cancer 2009;101:526-9. [PMID: 19550421 DOI: 10.1038/sj.bjc.6605146] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
29 Song HJ, Kim KM. Pathology of epstein-barr virus-associated gastric carcinoma and its relationship to prognosis. Gut Liver. 2011;5:143-148. [PMID: 21814592 DOI: 10.5009/gnl.2011.5.2.143] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
30 Neves M, Marinho-Dias J, Ribeiro J, Sousa H. Epstein-Barr virus strains and variations: Geographic or disease-specific variants? J Med Virol 2017;89:373-87. [PMID: 27430663 DOI: 10.1002/jmv.24633] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
31 Nishikawa J, Yoshiyama H, Iizasa H, Kanehiro Y, Nakamura M, Nishimura J, Saito M, Okamoto T, Sakai K, Suehiro Y. Epstein-barr virus in gastric carcinoma. Cancers (Basel). 2014;6:2259-2274. [PMID: 25386788 DOI: 10.3390/cancers6042259] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 5.5] [Reference Citation Analysis]
32 Bonequi P, Meneses-González F, Correa P, Rabkin CS, Camargo MC. Risk factors for gastric cancer in Latin America: a meta-analysis. Cancer Causes Control 2013;24:217-31. [PMID: 23224270 DOI: 10.1007/s10552-012-0110-z] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 7.6] [Reference Citation Analysis]
33 Niller HH, Wolf H, Minarovits J. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia. Semin Cancer Biol 2009;19:158-64. [PMID: 19429479 DOI: 10.1016/j.semcancer.2009.02.012] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 6.2] [Reference Citation Analysis]
34 Nandakumar A, Uwatoko F, Yamamoto M, Tomita K, Majima HJ, Akiba S, Koriyama C. Radiation-induced Epstein-Barr virus reactivation in gastric cancer cells with latent EBV infection. Tumour Biol 2017;39:1010428317717718. [PMID: 28675108 DOI: 10.1177/1010428317717718] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
35 Naseem M, Barzi A, Brezden-Masley C, Puccini A, Berger MD, Tokunaga R, Battaglin F, Soni S, McSkane M, Zhang W, Lenz HJ. Outlooks on Epstein-Barr virus associated gastric cancer. Cancer Treat Rev 2018;66:15-22. [PMID: 29631196 DOI: 10.1016/j.ctrv.2018.03.006] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 12.5] [Reference Citation Analysis]
36 Wang Y, Zhang X, Chao Y, Jia Y, Xing X, Luo B. New variations of Epstein-Barr virus-encoded small RNA genes in nasopharyngeal carcinomas, gastric carcinomas, and healthy donors in northern China. J Med Virol. 2010;82:829-836. [PMID: 20336720 DOI: 10.1002/jmv.21714] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
37 Lee JM, Kim H, Noh SH, Lee WY, Kim SJ, Park JH. Expression of Epstein-Barr Virus Gene and Clonality of Infiltrated T Lymphocytes in Epstein-Barr Virus-associated Gastric Carcinoma. Immune Netw. 2011;11:50-58. [PMID: 21494374 DOI: 10.4110/in.2011.11.1.50] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
38 Chen JN, Zhang NN, Jiang Y, Hui DY, Wen ZJ, Li HG, Ding YG, Du H, Shao CK. Variations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China. PLoS One 2012;7:e50084. [PMID: 23189182 DOI: 10.1371/journal.pone.0050084] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
39 Zhou F, Qiu LX, Cheng L, Wang MY, Li J, Sun MH, Yang YJ, Wang JC, Jin L, Wang YN, Wei QY. Associations of genotypes and haplotypes of IL-17 with risk of gastric cancer in an eastern Chinese population. Oncotarget 2016;7:82384-95. [PMID: 27577072 DOI: 10.18632/oncotarget.11616] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
40 Iizasa H, Nanbo A, Nishikawa J, Jinushi M, Yoshiyama H. Epstein-Barr Virus (EBV)-associated gastric carcinoma. Viruses. 2012;4:3420-3439. [PMID: 23342366 DOI: 10.3390/v4123420] [Cited by in Crossref: 127] [Cited by in F6Publishing: 114] [Article Influence: 14.1] [Reference Citation Analysis]
41 Shen H, Zhong M, Wang W, Liao P, Yin X, Rotroff D, Knepper TC, Mcleod HL, Zhou C, Xie S, Li W, Xu B, He Y. EBV infection and MSI status significantly influence the clinical outcomes of gastric cancer patients. Clin Chim Acta 2017;471:216-21. [PMID: 28601671 DOI: 10.1016/j.cca.2017.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
42 Han J, Chen JN, Zhang ZG, Li HG, Ding YG, Du H, Shao CK. Sequence variations of latent membrane protein 2A in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China. PLoS One 2012;7:e34276. [PMID: 22470549 DOI: 10.1371/journal.pone.0034276] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
43 朱晓芸, 李夏, 李素琴, 于红刚. EBV相关性胃癌研究进展. 世界华人消化杂志 2017; 25(15): 1375-1381 [DOI: 10.11569/wcjd.v25.i15.1375] [Reference Citation Analysis]
44 Menati Rashno M, Mehraban H, Naji B, Radmehr M. Microbiome in human cancers. Access Microbiol 2021;3:000247. [PMID: 34888478 DOI: 10.1099/acmi.0.000247] [Reference Citation Analysis]
45 Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S. Gastric adenocarcinoma. Nat Rev Dis Primers. 2017;3:17036. [PMID: 28569272 DOI: 10.1038/nrdp.2017.36] [Cited by in Crossref: 178] [Cited by in F6Publishing: 184] [Article Influence: 35.6] [Reference Citation Analysis]
46 Chen XZ, Chen H, Castro FA, Hu JK, Brenner H. Epstein-Barr virus infection and gastric cancer: a systematic review. Medicine (Baltimore) 2015;94:e792. [PMID: 25997049 DOI: 10.1097/MD.0000000000000792] [Cited by in Crossref: 65] [Cited by in F6Publishing: 42] [Article Influence: 9.3] [Reference Citation Analysis]
47 Yamamoto E, Suzuki H, Takamaru H, Yamamoto H, Toyota M, Shinomura Y. Role of DNA methylation in the development of diffuse-type gastric cancer. Digestion. 2011;83:241-249. [PMID: 21273772 DOI: 10.1159/000320453] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
48 Liu S, Zhao Z, Han L, Liu S, Luo B. Epstein-Barr Virus Infection in Gastric Remnant Carcinoma and Recurrent Gastric Carcinoma in Qingdao of Northern China. PLoS One 2016;11:e0148342. [PMID: 26859565 DOI: 10.1371/journal.pone.0148342] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
49 He CY, Qiu MZ, Yang XH, Zhou DL, Ma JJ, Long YK, Ye ZL, Xu BH, Zhao Q, Jin Y, Lu SX, Wang ZQ, Guan WL, Zhao BW, Zhou ZW, Shao JY, Xu RH. Classification of gastric cancer by EBV status combined with molecular profiling predicts patient prognosis. Clin Transl Med 2020;10:353-62. [PMID: 32508039 DOI: 10.1002/ctm2.32] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
50 Shukla SK, Prasad KN, Tripathi A, Ghoshal UC, Krishnani N, Husain N. Expression profile of latent and lytic transcripts of epstein-barr virus in patients with gastroduodenal diseases: a study from northern India. J Med Virol. 2012;84:1289-1297. [PMID: 22711358 DOI: 10.1002/jmv.23322] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
51 Zhang Y, Liu W, Zhang W, Wang W, Song Y, Xiao H, Luo B. Constitutive activation of the canonical NF-κB signaling pathway in EBV-associated gastric carcinoma. Virology 2019;532:1-10. [DOI: 10.1016/j.virol.2019.03.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
52 Rugge M, Fassan M, Graham DY. Epidemiology of Gastric Cancer. In: Strong VE, editor. Gastric Cancer. Cham: Springer International Publishing; 2015. pp. 23-34. [DOI: 10.1007/978-3-319-15826-6_2] [Cited by in Crossref: 68] [Cited by in F6Publishing: 17] [Article Influence: 9.7] [Reference Citation Analysis]
53 Na SJ, Park HL, O JH, Lee SY, Song KY, Kim SH. Correlation Between Infection Status of Epstein-Barr Virus and 18F-Fluorodeoxyglucose Uptake in Patients with Advanced Gastric Cancer. In Vivo 2017;31:749-53. [PMID: 28652452 DOI: 10.21873/invivo.11126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
54 Li X, Sun ZQ, Jiang XL. Advances in research of Epstein-Barr virus-associated gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2011; 19(32): 3323-3326 [DOI: 10.11569/wcjd.v19.i32.3323] [Reference Citation Analysis]
55 Piazuelo MB, Epplein M, Correa P. Gastric cancer: an infectious disease. Infect Dis Clin North Am 2010;24:853-69, vii. [PMID: 20937454 DOI: 10.1016/j.idc.2010.07.010] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.1] [Reference Citation Analysis]
56 Ryan JL, Jones RJ, Kenney SC, Rivenbark AG, Tang W, Knight ER, Coleman WB, Gulley ML. Epstein-Barr virus-specific methylation of human genes in gastric cancer cells. Infect Agent Cancer 2010;5:27. [PMID: 21194482 DOI: 10.1186/1750-9378-5-27] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
57 Tang F, Chen JN, Zhang NN, Gong LP, Jiang Y, Feng ZY, Xiao L, Li HG, Du H, Wu B, Shao CK. Expression of CCL21 by EBV-associated gastric carcinoma cells protects CD8+CCR7+ T lymphocytes from apoptosis via the mitochondria-mediated pathway. Pathology 2018;50:613-21. [PMID: 30149990 DOI: 10.1016/j.pathol.2018.05.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
58 García Aguilera X, Martín de Argila C, Vazquez Sequeiros E, Moreira Vicente V. [Lymphoepithelioma-like gastric carcinoma]. Med Clin (Barc) 2009;133:724-5. [PMID: 19243789 DOI: 10.1016/j.medcli.2008.11.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
59 Lu C, Zhang H, Zhou W, Wan X, Li L, Yu C. Epstein-Barr virus infection and genome polymorphisms on gastric remnant carcinoma: a meta-analysis. Cancer Cell Int. 2020;20:401. [PMID: 32843851 DOI: 10.1186/s12935-020-01498-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Horiguchi N, Tahara T, Kawamura T, Okubo M, Ishizuka T, Nakano N, Nakagawa Y, Nagasaka M, Nakagawa M, Tsukamoto T, Shibata T, Ohmiya N. Unusual growth of an Epstein-Barr virus-associated differentiated early-stage gastric carcinoma: A case report. Mol Clin Oncol 2018;8:657-60. [PMID: 29732154 DOI: 10.3892/mco.2018.1586] [Reference Citation Analysis]
61 Ali AS, Al-Shraim M, Al-Hakami AM, Jones IM. Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis. Open Virol J 2015;9:7-28. [PMID: 26862355 DOI: 10.2174/1874357901509010007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
62 Wang Y, Liu X, Xing X, Cui Y, Zhao C, Luo B. Variations of Epstein-Barr virus nuclear antigen 1 gene in gastric carcinomas and nasopharyngeal carcinomas from Northern China. Virus Res 2010;147:258-64. [PMID: 19941915 DOI: 10.1016/j.virusres.2009.11.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
63 Seo JS, Kim TG, Hong YS, Chen JY, Lee SK. Contribution of Epstein-Barr virus infection to chemoresistance of gastric carcinoma cells to 5-fluorouracil. Arch Pharm Res. 2011;34:635-643. [PMID: 21544729 DOI: 10.1007/s12272-011-0414-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
64 Chen JN, Jiang Y, Li HG, Ding YG, Fan XJ, Xiao L, Han J, Du H, Shao CK. Epstein-Barr virus genome polymorphisms of Epstein-Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, southern China, an endemic area of nasopharyngeal carcinoma. Virus Res 2011;160:191-9. [PMID: 21723347 DOI: 10.1016/j.virusres.2011.06.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
65 Lima Á, Sousa H, Medeiros R, Nobre A, Machado M. PD-L1 expression in EBV associated gastric cancer: a systematic review and meta-analysis. Discov Oncol 2022;13:19. [PMID: 35318527 DOI: 10.1007/s12672-022-00479-0] [Reference Citation Analysis]
66 Nie Y, Sun Y, Wang Y, Liu C, Zhao C, Luo B. Epstein-Barr virus gene polymorphism in different parts of the same nasopharyngeal carcinoma patient. Arch Virol 2013;158:1031-7. [DOI: 10.1007/s00705-012-1578-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
67 Liu X, Tang X, Zhang S, Wang Y, Wang X, Zhao C, Luo B. Methylation and Expression of Retinoblastoma and Transforming Growth Factor-β1 Genes in Epstein-Barr Virus-Associated and -Negative Gastric Carcinomas. Gastroenterol Res Pract 2012;2012:906017. [PMID: 23008701 DOI: 10.1155/2012/906017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
68 Wang W, Wang K, Chen Z, Chen L, Guo W, Liao P, Rotroff D, Knepper TC, Liu Z, Zhang W, Mcleod HL, He Y. Immunoclassification characterized by CD8 and PD-L1 expression is associated with the clinical outcome of gastric cancer patients. Oncotarget 2018;9:12164-73. [PMID: 29552300 DOI: 10.18632/oncotarget.24037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
69 Cárdenas-Mondragón MG, Carreón-Talavera R, Camorlinga-Ponce M, Gomez-Delgado A, Torres J, Fuentes-Pananá EM. Epstein Barr virus and Helicobacter pylori co-infection are positively associated with severe gastritis in pediatric patients. PLoS One. 2013;8:e62850. [PMID: 23638154 DOI: 10.1371/journal.pone.0062850] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
70 Osumi H, Kawachi H, Yoshio T, Fujisaki J. Clinical impact of Epstein‐Barr virus status on the incidence of lymph node metastasis in early gastric cancer. Digestive Endoscopy 2020;32:316-22. [DOI: 10.1111/den.13584] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
71 Danilova NV, Mikhailov IA, Kalinin DV, Oleynikova NA, Chayka AV, Khomyakov VM, Kakotkin VV, Yudin MY, Vychuzhanin DV, Andreeva YY, Malkov PG. [Study of gastric adenocarcinomas association with the Epstein-Barr virus-encoded small RNAs]. Arkh Patol 2022;84:5-12. [PMID: 35417943 DOI: 10.17116/patol2022840215] [Reference Citation Analysis]
72 Murphy G, Pfeiffer R, Camargo MC, Rabkin CS. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology 2009;137:824-33. [PMID: 19445939 DOI: 10.1053/j.gastro.2009.05.001] [Cited by in Crossref: 253] [Cited by in F6Publishing: 231] [Article Influence: 19.5] [Reference Citation Analysis]
73 Cárdenas-Mondragón MG, Torres J, Sánchez-Zauco N, Gómez-Delgado A, Camorlinga-Ponce M, Maldonado-Bernal C, Fuentes-Pananá EM. Elevated Levels of Interferon-γ Are Associated with High Levels of Epstein-Barr Virus Reactivation in Patients with the Intestinal Type of Gastric Cancer. J Immunol Res 2017;2017:7069242. [PMID: 29349089 DOI: 10.1155/2017/7069242] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
74 Park HY, Kang SY, Kang GH, Bae GE, Lee SE, Kim K, Park CK, Choi MG, Noh JH, Sohn TS, Bae JM, Kim S. EBV infection and mismatch repair deficiency mediated by loss of hMLH1 expression contribute independently to the development of multiple synchronous gastric carcinomas: EBV and hMLH1 in Multiple Gastric Carcinomas. J Surg Oncol 2012;106:777-82. [DOI: 10.1002/jso.23131] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
75 Fukayama M, Hino R, Uozaki H. Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma. Cancer Sci. 2008;99:1726-1733. [PMID: 18616681 DOI: 10.1111/j.1349-7006.2008.00888.x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 104] [Article Influence: 7.5] [Reference Citation Analysis]
76 Shin HJ, Kim do N, Lee SK. Association between Epstein-Barr virus infection and chemoresistance to docetaxel in gastric carcinoma. Mol Cells. 2011;32:173-179. [PMID: 21626300 DOI: 10.1007/s10059-011-0066-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
77 Sandoval-Bórquez A, Saavedra K, Carrasco-Avino G, Garcia-Bloj B, Fry J, Wichmann I, Corvalán AH. Noncoding Genomics in Gastric Cancer and the Gastric Precancerous Cascade: Pathogenesis and Biomarkers. Dis Markers 2015;2015:503762. [PMID: 26379360 DOI: 10.1155/2015/503762] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
78 Wang Y, Wang XF, Sun ZF, Luo B. Unique variations of Epstein-Barr virus-encoded BARF1 gene in nasopharyngeal carcinoma biopsies. Virus Res 2012;166:23-30. [PMID: 22406129 DOI: 10.1016/j.virusres.2012.02.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
79 Song H, Srivastava A, Lee J, Kim YS, Kim K, Ki Kang W, Kim M, Kim S, Park CK, Kim S. Host Inflammatory Response Predicts Survival of Patients With Epstein-Barr Virus–Associated Gastric Carcinoma. Gastroenterology 2010;139:84-92.e2. [DOI: 10.1053/j.gastro.2010.04.002] [Cited by in Crossref: 104] [Cited by in F6Publishing: 100] [Article Influence: 8.7] [Reference Citation Analysis]
80 Hatakeyama M. Structure and function of Helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93:196-219. [PMID: 28413197 DOI: 10.2183/pjab.93.013] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 12.2] [Reference Citation Analysis]
81 Liu Y, Yang W, Pan Y, Ji J, Lu Z, Ke Y. Genome-wide analysis of Epstein-Barr virus (EBV) isolated from EBV-associated gastric carcinoma (EBVaGC). Oncotarget. 2016;7:4903-4914. [PMID: 26716899 DOI: 10.18632/oncotarget.6751] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
82 Power C, Antony JM, Ellestad KK, Deslauriers A, Bhat R, Noorbakhsh F. The human microbiome in multiple sclerosis: pathogenic or protective constituents? Can J Neurol Sci 2010;37 Suppl 2:S24-33. [PMID: 21246932 DOI: 10.1017/s031716710002240x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
83 Hatakeyama M. Malignant Helicobacter pylori-Associated Diseases: Gastric Cancer and MALT Lymphoma. In: Kamiya S, Backert S, editors. Helicobacter pylori in Human Diseases. Cham: Springer International Publishing; 2019. pp. 135-49. [DOI: 10.1007/5584_2019_363] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
84 Zhu S, Sun P, Zhang Y, Yan L, Luo B. Expression of c-myc and PCNA in Epstein-Barr virus-associated gastric carcinoma. Exp Ther Med. 2013;5:1030-1034. [PMID: 23599727 DOI: 10.3892/etm.2013.972] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
85 Osumi H, Kawachi H, Yoshio T, Ida S, Yamamoto N, Horiuchi Y, Ishiyama A, Hirasawa T, Tsuchida T, Hiki N, Takeuchi K, Fujisaki J. Epstein-Barr virus status is a promising biomarker for endoscopic resection in early gastric cancer: proposal of a novel therapeutic strategy. J Gastroenterol 2019;54:774-83. [PMID: 30826866 DOI: 10.1007/s00535-019-01562-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
86 Hatta MNA, Mohamad Hanif EA, Chin SF, Neoh HM. Pathogens and Carcinogenesis: A Review. Biology (Basel) 2021;10:533. [PMID: 34203649 DOI: 10.3390/biology10060533] [Reference Citation Analysis]
87 Alarcón A, Figueroa U, Espinoza B, Sandoval A, Carrasco-aviño G, Aguayo FR, Corvalan AH. Epstein-Barr Virus–Associated Gastric Carcinoma: The Americas’ Perspective. In: Mózsik G, Karádi O, editors. Gastric Cancer. InTech; 2017. [DOI: 10.5772/intechopen.70201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
88 Openshaw MR, Richards CJ, Guttery DS, Shaw JA, Thomas AL. The genetics of gastroesophageal adenocarcinoma and the use of circulating cell free DNA for disease detection and monitoring. Expert Review of Molecular Diagnostics 2017;17:459-70. [DOI: 10.1080/14737159.2017.1308824] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
89 Jiang Y, Xiao H, Sun L, Zhang Y, Liu S, Luo B. LMP2A suppresses the role of AHR pathway through ERK signal pathway in EBV-associated gastric cancer. Virus Res 2021;297:198399. [PMID: 33753181 DOI: 10.1016/j.virusres.2021.198399] [Reference Citation Analysis]
90 Fukayama M. Epstein-Barr virus and gastric carcinoma. Pathol Int. 2010;60:337-350. [PMID: 20518883 DOI: 10.1111/j.1440-1827.2010.02533.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 79] [Article Influence: 7.3] [Reference Citation Analysis]
91 He D, Zhang Y, Zhang N, Zhou L, Chen J, Jiang Y, Shao C. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein–Barr virus-associated gastric carcinomas. Med Oncol 2015;32. [DOI: 10.1007/s12032-015-0525-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
92 Boysen T, Friborg J, Stribolt K, Hamilton-Dutoit S, Goertz S, Wohlfahrt J, Melbye M. Epstein-Barr virus-associated gastric carcinoma among patients with pernicious anemia. Int J Cancer 2011;129:2756-60. [PMID: 21225628 DOI: 10.1002/ijc.25925] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
93 Bae JM, Kim EH. Epstein-Barr Virus and Gastric Cancer Risk: A Meta-analysis With Meta-regression of Case-control Studies. J Prev Med Public Health. 2016;49:97-107. [PMID: 27055546 DOI: 10.3961/jpmph.15.068] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
94 Leiting JL, Grotz TE. Advancements and challenges in treating advanced gastric cancer in the West. World J Gastrointest Oncol 2019; 11(9): 652-664 [PMID: 31558971 DOI: 10.4251/wjgo.v11.i9.652] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]